SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddys Laboratories informs about press release

28 Oct 2020 Evaluate

Dr. Reddys Laboratories has informed that it has enclosed a Press Release in term of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on 28 October 2020 titled ‘Dr. Reddy's Laboratories announces appointment of new Chief Financial Officer’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1339.35 -17.50 (-1.29%)
01-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1865.95
Dr. Reddys Labs. 1339.35
Cipla 1456.95
Zydus Lifesciences 1108.85
Lupin 2396.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: